GLPG0634 analogue

CAS No. 1206101-20-3

GLPG0634 analogue( Filgotinib-analogue, GLPG0634-analogue )

Catalog No. M17191 CAS No. 1206101-20-3

GLPG0634 (analog) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 132 In Stock
25MG 249 In Stock
50MG 441 In Stock
100MG 624 In Stock
500MG 1305 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GLPG0634 analogue
  • Note
    Research use only, not for human use.
  • Brief Description
    GLPG0634 (analog) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.
  • Description
    GLPG0634-analogue is an analogue of Filgotinib or GLPG0634, is a potent and selective JAK1 inhibitor.
  • In Vitro
    GLPG0634 analog (Compoun 176) inhibits JAK-STAT signaling and OSM/IL-lβ signaling with both EC50 values of 101-500 nM.GLPG0634 analog shows microsomal stability of 76%-100% in rat and human.
  • In Vivo
    ——
  • Synonyms
    Filgotinib-analogue, GLPG0634-analogue
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    JAK1| JAK2| JAK3
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1206101-20-3
  • Formula Weight
    425.5
  • Molecular Formula
    C21H23N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 53 mg/mL 129.13 mM
  • SMILES
    O=C(C1CC1)Nc1nn2c(c3ccc(OCc4ccc(C#N)nc4)cc3)cccc2n1
  • Chemical Name
    N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-cyclopropanecarboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Van Rompaey L, et al. J Immunol. 2013, 191(7), 3568-3577.
molnova catalog
related products
  • cis-PDA

    cis-PDA is a general ionotropic receptor antagonist. cis-PDA acts by blocking NMDA, AMPA, and kainate-mediated responses.

  • VU6012962

    VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).

  • S-(4-Hydroxybenzyl)g...

    L-γ-Glutamyl-S-[(4-hydroxyphenyl)methyl] was isolated as the major principle responsible for the inhibition of the in vitro binding of kainic acid to brain glutamate receptors by water extracts of the plant Gastrodia elata.